NASDAQ:NMRD
Nemaura Medical Inc. Stock News
$0.0311
-0.0039 (-11.14%)
At Close: May 10, 2024
CompuGroup Medical Societas Europaea : lays foundation for further growth with conversion into new legal form | MarketScreener
10:45am, Thursday, 18'th Jun 2020Alliancebernstein L.P. Acquires 8,939 Shares of DexCom, Inc. (NASDAQ:DXCM)
08:13am, Thursday, 18'th Jun 2020
Alliancebernstein L.P. lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM) by 17.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 61,309 shares o
Cegedim Health Data collabore avec IBM Watson Health pour fournir un accès aux données de vie réelle
12:00am, Thursday, 18'th Jun 2020
16 juin 2020 - Cegedim Health Data annonce une collaboration avec IBM Watson Health pour l’intégration des données cliniques de vie réelle THIN®, The...
CHINA MERCHANTS PORT HOLDINGS COMPANY LIMITED : Détachement de dividende scrip | Zone bourse
10:00pm, Wednesday, 17'th Jun 2020The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
12:00am, Wednesday, 17'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hour.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
ADC Therapeutics SA (NYSE:...
Wearables Market Has Banner Year, and then Came COVID-19
04:06pm, Tuesday, 16'th Jun 2020
In 2019, the wearables market reported the largest single-year growth in revenue since 2015, when such high-profile devices as the Apple Watch were launched, according to IDTechEx. Much of the market
BBB seeks applications for post of IFCI MD
02:05pm, Tuesday, 16'th Jun 2020
Currently, Emandi Sankara Rao, is the MD and CEO of IFCI, appointed in August 2017 for the period of three years. The Prime Minister, in 2016, approved the constitution of BBB as a body of eminent pr
Eli Lilly and : FDA approves Lyumjev (insulin lispro-aabc injection), Lilly's new rapid-acting insulin | MarketScreener
12:05pm, Tuesday, 16'th Jun 2020Nemaura Participated as Guest Speaker at DiabetesMine™ D-Data ExChange 2020
10:45am, Tuesday, 16'th Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Eli Lilly and : FDA approves Lyumjev™ (insulin lispro-aabc injection), Lilly's new rapid-acting insulin | MarketScreener
02:23am, Tuesday, 16'th Jun 2020Global Smart Insulin Pens Market 2020-2030 with COVID-19 Adjusted Forecasts - ResearchAndMarkets.com
12:00am, Tuesday, 16'th Jun 2020
The
Abbott gets FDA clearance for newest CGM
11:37pm, Monday, 15'th Jun 2020
Abbott Laboratories received FDA clearance for its newest continuous glucose monitor, the FreeStyle Libre 2. The product is one of many in a growing market for CGMs.
Diabetes Treatment: How Abbott Plans To Rival Dexcom With A New Device | Investor's Business Daily
04:57pm, Monday, 15'th Jun 2020
Abbott Laboratories is closing the competitive gap with Dexcom after gaining U.S. clearance for a next-generation diabetes treatment device.
